A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
This study is conducted to select the THR-149 dose level (Part A of the study) and to assess
the efficacy and safety of the selected dose level compared to aflibercept (Part B of the
study).